59
Participants
Start Date
June 23, 2016
Primary Completion Date
August 18, 2017
Study Completion Date
August 18, 2017
Teduglutide 0.05mg/kg
0.05 mg/kg
Teduglutide 0.025 mg/kg
0.025 mg/kg
Standard of Care
Observational cohort for the 24-week treatment period and 4 week follow-up.
Cliniques Universitaires Saint-Luc, Brussels
Children's Hospital GI Nutrition, New York
Montefiore Medical Center Child Spc, The Bronx
University of Pennsylvania Medical Center, Philadelphia
Georgetown Children's Research Network, Washington D.C.
Duke Medical Center, Durham
Cleveland Clinic Pediatric Specialists, Cleveland
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children, Indianapolis
University of Wisconsin School of Medicine and Public Health, Madison
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
The Nebraska Medical Center, Omaha
Universitaetsklinikum Tuebingen, Tübingen
Children's Medical Center Dallas, Dallas
Texas Children's Hospital, Houston
Children's Hospital Los Angeles - RHU, Los Angeles
UCLA Dept. of Medicine, Los Angeles
UCSF Benioff Children's Hospital, San Francisco
Seattle Children's Hospital, Seattle
Boston Children's Hospital, Boston
Walter C. Mackenzie Health Science Center, Edmonton
British Columbia Children's & Women's Hospital Center, Vancouver
The Hospital for Sick Children, Toronto
Helsingin yliopistollinen keskussairaala, Helsinki
Ospedale Pediatrico Bambino Gesu, Roma
Great Ormond Street Hospital for Children, London
Birmingham Children's Hospital, Birmingham
Lead Sponsor
Shire
INDUSTRY